NSG 6005 ADVANCED PHARMACOLOGY FINAL EXAM TEST BANK

NSG 6005 ADVANCED PHARMACOLOGY FINAL EXAM
TEST BANK
Chapter 1. The Role of the Nurse Practitioner
A A A A A A A




1. NurseApractitionerAprescriptiveAauthorityAisAregulatedAby:

A. TheANationalACouncilAofAStateABoardsAofANursing
B. TheAU.S.ADrugAEnforcementAAdministration
C. TheAStateABoardAofANursingAforAeachAstate
D. TheAStateABoardAofAPharmacy



2. TheAbenefitsAtoAtheApatientAofAhavingAanAAdvancedAPracticeARegisteredA
Nurse (APRN) prescriber include:
A A A




A. NursesAknowAmoreAaboutAPharmacologyAthanAotherAprescribersAb
ecause they take it both in their basic nursing program & in their A
A A A A A A A A A A A A A


PRN program.
A


B. Nurses care for the patient from a holistic approach & include the
A A A A A A A A A A A A


patient in decision making regarding their care.
A A A A A A


C. APRNs are less likely to prescribe narcotics & other controlled
A A A A A A A A A A


substances.
D. APRNs are able to prescribe independently in all states, whereas a
A A A A A A A A A A A


physician’s assistant needs to have a physician supervising their pr
A A A A A A A A A


actice.


3. ClinicalAjudgmentAinAprescribingAincludes:

A. FactoringAinAtheAcostAtoAtheApatientAofAtheAmedicationAprescribed
B. AlwaysAprescribingAtheAnewestAmedicationAavailableAforAtheAdiseaseA
process
C. Hiring out drug samples to poor patients
A A A A A A


D. Prescribing all generic medications to cut costs
A A A A A A




4. CriteriaAforAchoosingAanAeffectiveAdrugAforAaAdisorderAinclude:

A. AskingAtheApatientAwhatAdrugAtheyAthinkAwouldAworkAbestAforAthem

, B. ConsultingAnationallyArecognizedAguidelinesAforAdiseaseAmanagement
C. PrescribingAmedicationsAthatAareAavailableAasAsamplesAbeforeAwritingAaA
prescription
D. Following U.S. Drug Enforcement Administration guidelines for
A A A A A A A


prescribing


5. NurseApractitionerApracticeAmayAthriveAunderAhealth-
care reform because of:
A A A




A. TheAdemonstratedAabilityAofAnurseApractitionersAtoAcontrolAcostsA&Ai
mprove patient outcomes A A


B. The fact that nurse practitioners will be able to practice independently
A A A A A A A A A A


C. The fact that nurse practitioners will have full reimbursement under
A A A A A A A A A A


healthcare reform A


D. The ability to shift accountability for Medicaid to the state level
A A A A A A A A A A




Chapter 2. Review of Basic Principles of Pharmacology
A A A A A A A




A patient’s nutritional intake & laboratory results reflect hypoalbuminemia. This is cr
A A A A A A A A A A A


itical to prescribing because:
A A A




A.A DistributionAofAdrugsAtoAtargetAtissueAmayAbeAaffected.
B.The solubility of the drug will not match the site of absorption.
A A A A A A A A A A A


C.There will be less free drug available to generate an effect.
A A A A A A A A A A


D.Drugs bound to albumin are readily excreted by the kidneys.
A A A A A A A A A




Drugs that have a significant first-pass effect:
A A A A A A




A.Must be given by the enteral (oral) route only
A A A A A A A A


B.Bypass the hepatic circulationA A A


C. Are rapidly metabolized by the liver & may have little if any desired action
A A A A A A A A A A A A A A




D. Are converted by the liver to more active & fat-soluble forms
A A A A A A A A A A A




The route of excretion of a volatile drug will likely be the: A.Kidney
A A A A A A A A A A A A




s

, B.Lungs C.Bil A


e & feces D.S
A A A


kin


Medroxyprogesterone (Depo Provera) is prescribed intramuscularly (IM) to create A A A A A A A A A


a storage reservoir of the drug. Storage reservoirs:
A A A A A A A




A.Assure that the drug will reach its intended target tissue
A A A A A A A A A


B.Are the reason for giving loading doses
A A A A A A


C.Increase the length of time a drug is available & active
A A A A A A A A A A


D.Are most common in collagen tissues
A A A A A




The NP chooses to give cephalexin every 8 hours based on knowledge of the drug’
A A A A A A A A A A A A A A


s:
A.Propensity to go to the target receptor B A A A A A A A


.Biological half-life C.Pharmacodynamics
A A


DSafety & side effects
A A A




.Azithromycin dosing requires that the first day’s dosage be twice those of the
A A A A A A A A A A A A A


other 4 days of the prescription. This is considered a loading dose. A loading d
A A A A A A A A A A A A A A


ose:
A.Rapidly achieves drug levels in the therapeutic range
A A A A A A A


B.Requires four- to five-half-lives to attain
A A A A A


C.Is influenced by renal function
A A A A


D.Is directly related to the drug circulating to the target tissues
A A A A A A A A A A




The point in time on the drug concentration curve that indicates the first sign of a th
A A A A A A A A A A A A A A A A


erapeutic effect is the: A A A




A.Minimum adverse effect level A A A


B.Peak of action A A


C.Onset of action D.Therapeuti
A A A


c range
A




Phenytoin requires that a trough level be drawn. Peak & trough levels are done:
A A A A A A A A A A A A A

, A.When the drug has a wide therapeutic range
A A A A A A A


B.When the drug will be administered for a short time only
A A A A A A A A A A


C.When there is a high correlation between the dose & saturation of receptor si
A A A A A A A A A A A A A


tes
B. To determine if a drug is in the therapeutic range
A A A A A A A A A A




A laboratory result indicates that the peak level for a drug is above the minimum tox
A A A A A A A A A A A A A A A


ic concentration. This means that the:
A A A A A


A.Concentration will produce therapeutic effects B.Co A A A A A


ncentration will produce an adverse response C.Time
A A A A A A


Abetween doses must be shortened D.Duration of acti
A A A A A A A


on of the drug is too long
A A A A A A




Drugs that are receptor agonists may demonstrate what property?
A A A A A A A A A




A.Irreversible binding to the drug receptor siteA A A A A A


B.Upregulation with chronic use A A A


C.Desensitization or downregulation with continuous use D.Inver A A A A A A


se relationship between drug concentration & drug action
A A A A A A A




Drugs that are receptor antagonists, such as beta blockers, may cause: A.Downreg
A A A A A A A A A A A




ulation of the drug receptor
A A A A


B.An exaggerated response if abruptly discontinued
A A A A A


C.Partial blockade of the effects of agonist drugs
A A A A A A A


D.An exaggerated response to competitive drug agonists
A A A A A A